Sector Gamma AS’s Syndax Pharmaceuticals SNDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$4.54M Hold
241,739
– – 0.94% 32
2026
Q2
$5.28M Sell
241,739
-44,268
-15% -$921K 1.15% 30
2026
Q1
$6.68M Buy
286,007
+33,945
+13% +$738K 1.58% 22
2025
Q4
$5.3M Buy
252,062
+41,248
+20% +$720K 1.21% 28
2025
Q3
$3.24M Buy
+210,814
New +$2.76M 0.8% 37

Other funds holding SNDX

Sector Gamma AS's SNDX Position: Q3 2026 in Review

Sector Gamma AS held its Syndax Pharmaceuticals (SNDX) position steady in Q3 2026 at 241,739 shares worth $4.54M. The position accounts for 0.94% of the portfolio, ranked #32.

Sector Gamma AS first reported a position in SNDX in Q3 2025 and has held it in 5 quarters since. The position peaked at $6.68M in Q1 2026. 237 funds tracked by Wall St. Rank hold SNDX as of Q3 2026.

  • Sector Gamma AS held 241,739 shares of Syndax Pharmaceuticals worth $4.54M as of Q3 2026.
  • Sector Gamma AS left its Syndax Pharmaceuticals share count unchanged in Q3 2026.
  • Syndax Pharmaceuticals made up 0.94% of Sector Gamma AS's portfolio in Q3 2026, its #32 holding.
  • Sector Gamma AS first reported a position in Syndax Pharmaceuticals in Q3 2025 and has held it in 5 quarters since.
  • Sector Gamma AS's Syndax Pharmaceuticals position peaked at $6.68M in Q1 2026.
  • 237 funds tracked by Wall St. Rank held Syndax Pharmaceuticals as of Q3 2026.

Based on Sector Gamma AS's 13F filing for Q3 2026, filed 12 Nov 2026.